HBC Financial Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-221
Closed -$5K 199
2023
Q1
$5K Hold
221
﹤0.01% 142
2022
Q4
$6K Buy
221
+214
+3,057% +$5.47K ﹤0.01% 124
2022
Q3
$0 Sell
7
-214
-97% -$6.46K ﹤0.01% 179
2022
Q2
$7K Hold
221
0.01% 132
2022
Q1
$6K Hold
221
﹤0.01% 130
2021
Q4
$6K Hold
221
﹤0.01% 131
2021
Q3
$7K Hold
221
﹤0.01% 121
2021
Q2
$6K Buy
+221
New +$7.28K ﹤0.01% 135

Other funds holding OGN

HBC Financial Services's OGN Position: Q2 2023 in Review

HBC Financial Services sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 221 shares — an estimated $5K sold.

HBC Financial Services first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $7K in Q2 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • HBC Financial Services reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • HBC Financial Services sold 221 Organon & Co shares in Q2 2023, an estimated $5K.
  • HBC Financial Services first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • HBC Financial Services's Organon & Co position peaked at $7K in Q2 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on HBC Financial Services's 13F filing for Q2 2023, filed 27 Jul 2023.